Pharmaceutical compositions and methods of inhibiting phenylethanolamine
申请人:SmithKline Corporation
公开号:US03988339A1
公开(公告)日:1976-10-26
Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase using 7 and/or 8 substituted 1,2,3,4-tetrahydroisoquinoline compounds.
制药组合物和使用7和/或8取代的1,2,3,4-四氢异喹啉化合物抑制苯乙醇胺N-甲基转移酶的方法。
[EN] BET INHIBITORS FOR MODULATING DUX4 EXPRESSION IN FSHD<br/>[FR] INHIBITEURS DE BET POUR MODULER L'EXPRESSION DE DUX4 DANS LA FSHD
申请人:UNIV SAINT LOUIS
公开号:WO2020132004A1
公开(公告)日:2020-06-25
The present disclosure provides BET inhibitors of the formula: wherein the variables are defined herein, as well as pharmaceutical compositions thereof. The present disclosure also provides methods of treating a patient comprising administering a bromo- and extra-terminal (BET) domain inhibitor for the treatment of FSHD which modulates DUX4 expression. In some embodiments, the present methods comprise using one or more BET inhibitors as a therapeutic agent for the treatment of FSHD patients including patients who are being treated with one or more palliative treatments such as therapy and/or agents which lead to increased muscle mass.
[EN] METHOD FOR THE SYNTHESIS OF AN AMINO ACETAL<br/>[FR] PROCÉDÉ DE SYNTHÈSE D'UN AMINO-ACÉTAL
申请人:UNIV NANYANG TECH
公开号:WO2012005693A1
公开(公告)日:2012-01-12
The present invention relates to a method for the synthesis of an α amino acetal, comprising (i) oxidizing a tertiary amine in the presence of a copper catalyst, at least one oxidant and a solvent, or (ii) reacting a secondary amine and an aliphatic aldehyde in the presence of a copper catalyst, at least one oxidant and a solvent.
本发明涉及一种合成α氨基缩醛的方法,包括 (i) 在铜催化剂、至少一种氧化剂和溶剂的存在下氧化三级胺,或者 (ii) 在铜催化剂、至少一种氧化剂和溶剂的存在下使二级胺和脂肪族醛发生反应。
Self- and hydroxyl reactive formaldehyde-free cyclic hemiamidal and
申请人:Air Products and Chemicals, Inc.
公开号:US04691026A1
公开(公告)日:1987-09-01
A compound represented by the following formula: ##STR1## wherein R is a C.sub.3 -C.sub.24 olefinically unsaturated organic radical having functionality which renders the nitrogen atom electron deficient, the olefinic unsaturation functionality being polymerizable, R.sup.1 is hydrogen or a C.sub.1 -C.sub.4 alkyl radical, or R and R.sup.1 together with the nitrogen atom can form an olefinically unsaturated 5 to 7-member ring which has functionality that renders the nitrogen atom electron deficient and the olefinic unsaturation functionality is polymerizable, R.sup.2 and R.sup.3 are hydrogen, a C.sub.1 -C.sub.4 alkyl or acyl radical, or R.sup.2 and R.sup.3 together are a C.sub.2 -C.sub.4 alkylene group, R.sup.4 is hydrogen or a C.sub.1 -C.sub.4 alkyl, acyl, ester, amide or acid group, and n is an integer from 1 to 10, provided n is not 1 when R is (meth)acryloyl, R.sup.2 and R.sup.3 are methyl and R.sup.1 and R.sup.4 are hydrogen. Under acidic conditions the above compounds having R.sup.1 =hydrogen afford cyclic hemiamidals and hemiamide ketals of the following formula ##STR2##
Coating composition comprising a compound comprising at least one bicyclo-orthoester group and at least one other functional group
申请人:Hobel Klaus
公开号:US06979719B1
公开(公告)日:2005-12-27
The invention pertains to a coating composition comprising a compound comprising at least one bicyclo-orthoester group and at least one other functional group. The invention also comprises a process for curing the present coating composition. Further, a process for making a bicyclo-orthoester-functional compound from the corresponding oxetane compound is described.